Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review

A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests reveale...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 59; no. 1; pp. 113 - 118
Main Authors Shishido, Tsutomu, Shimizu, Kunihiko, Kazumoto, Hiroko, Ueki, Toshimitsu, Sato, Keijiro, Kitahara, Mari, Hiroshima, Yuki, Kirihara, Takehiko, Sumi, Masahiko, Uematsu, Nozomu, Kobayashi, Hikaru
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 01.01.2020
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
AbstractList A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
Author Uematsu, Nozomu
Ueki, Toshimitsu
Kitahara, Mari
Shimizu, Kunihiko
Hiroshima, Yuki
Shishido, Tsutomu
Kobayashi, Hikaru
Kazumoto, Hiroko
Sato, Keijiro
Sumi, Masahiko
Kirihara, Takehiko
Author_xml – sequence: 1
  fullname: Shishido, Tsutomu
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Shimizu, Kunihiko
  organization: Department of Cardiology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Kazumoto, Hiroko
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Ueki, Toshimitsu
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Sato, Keijiro
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Kitahara, Mari
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Hiroshima, Yuki
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Kirihara, Takehiko
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Sumi, Masahiko
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Uematsu, Nozomu
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
– sequence: 1
  fullname: Kobayashi, Hikaru
  organization: Department of Hematology, Nagano Red Cross Hospital, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31462594$$D View this record in MEDLINE/PubMed
BookMark eNqNkktvEzEQx1eoiKaFr4AsceGyxWt7H-aAFCJeUgAJytmaeGcTB8dObSdVb3x0vEoIUC5cZiT7N_95XhRnzjssClLRK1Y18oVxCYMDu8HeaOPwinPGyko-KCYVF7JsGa_PigmVVVeybM6LixjXlPKulexRcc4r0bBaiknx4-Od1xB6k0wktyatyLTfg9PYk2kKxu_RZad3FgJ5bb3-TmDIucnUWr9Eh0aTrwk3ZIbWkusALm4tuATJePeSTMkMIpIvuPUhEXA9mZscDWkXxte9wdvHxcMBbMQnR39ZfHv75nr2vpx_fvdhNp2XuqEylSBgYIMAxhadHjT0bd007dDomvNh0QhGKS4kBdEMney0EAs59B3oFgfKGdb8snh10N3uFnlseuwLrNoGs4FwpzwY9fePMyu19HvVSFm3VGSB50eB4G92GJPamKhz2-DQ76JirGM1FVXXZPTZPXTtd-O-MsXz7GtRCZmpp39WdCrl13Iy0B0AHXyMAYcTUlE13oG6fwdqvANVyd_dnkK1OSwl92bs_wh8OgisY4IlnjJDSEZb_DewlqoazVHgBOoVBIWO_wRHfOGC
CitedBy_id crossref_primary_10_1016_j_jtct_2022_05_038
crossref_primary_10_1016_j_jemermed_2022_09_021
crossref_primary_10_7759_cureus_40439
Cites_doi 10.1016/j.jacc.2011.09.074
10.1016/j.bbmt.2005.07.002
10.1152/ajpheart.00154.2007
10.1038/sj.bmt.1701038
10.11406/rinketsu.56.485
10.1002/14651858.CD004471.pub3
10.1038/sj.bmt.1705869
10.1161/CIRCRESAHA.115.306573
10.1093/eurheartj/ehq493
10.1080/10428194.2016.1266623
10.1007/s12185-009-0332-3
10.1038/sj.bmt.1702744
10.1038/bmt.2017.114
10.1007/s00277-006-0192-3
10.1182/blood-2009-12-261586
10.1200/JCO.1995.13.9.2401
ContentType Journal Article
Copyright 2020 by The Japanese Society of Internal Medicine
Copyright Japan Science and Technology Agency 2020
Copyright © 2020 by The Japanese Society of Internal Medicine
Copyright_xml – notice: 2020 by The Japanese Society of Internal Medicine
– notice: Copyright Japan Science and Technology Agency 2020
– notice: Copyright © 2020 by The Japanese Society of Internal Medicine
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
H94
K9.
7X8
5PM
DOI 10.2169/internalmedicine.3322-19
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE


AIDS and Cancer Research Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 118
ExternalDocumentID PMC6995704
31462594
10_2169_internalmedicine_3322_19
article_internalmedicine_59_1_59_3322_19_article_char_en
Genre Journal Article
Review
Case Reports
Report
Case Study
GroupedDBID ---
29J
2WC
5GY
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
HYE
JSF
JSH
M48
OK1
OVT
P2P
PGMZT
RJT
RNS
RPM
RZJ
TR2
XSB
AAYXX
CITATION
7.U
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7T5
7TK
7U9
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c609t-a4af2f4a22b8cfcad75667f6c533fb64200eb90a46f898c44b9fd8ac7ef032e53
IEDL.DBID M48
ISSN 0918-2918
1349-7235
IngestDate Thu Aug 21 18:04:49 EDT 2025
Fri Jul 11 06:16:12 EDT 2025
Mon Jun 30 07:51:14 EDT 2025
Thu Jan 02 22:58:15 EST 2025
Thu Apr 24 22:51:10 EDT 2025
Tue Jul 01 01:40:13 EDT 2025
Wed Sep 03 06:25:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords allogeneic stem cell transplantation
atrioventricular block
myocarditis
graft-versus-host disease
Language English
License The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c609t-a4af2f4a22b8cfcad75667f6c533fb64200eb90a46f898c44b9fd8ac7ef032e53
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Report-1
ObjectType-Review-5
ObjectType-Feature-4
content type line 23
ObjectType-Article-3
Correspondence to Dr. Masahiko Sumi, sumin@nagano-med.jrc.or.jp
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2169/internalmedicine.3322-19
PMID 31462594
PQID 2331454149
PQPubID 2048449
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6995704
proquest_miscellaneous_2282504186
proquest_journals_2331454149
pubmed_primary_31462594
crossref_primary_10_2169_internalmedicine_3322_19
crossref_citationtrail_10_2169_internalmedicine_3322_19
jstage_primary_article_internalmedicine_59_1_59_3322_19_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 2020
Publisher The Japanese Society of Internal Medicine
Japan Science and Technology Agency
Publisher_xml – name: The Japanese Society of Internal Medicine
– name: Japan Science and Technology Agency
References 19. Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev 18: CD004471, 2013.
2. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 59: 779-792, 2012.
8. Bhattacharya S, Paneesha S, Chaganti S, et al. "Viral" myocarditis in a patient following allogenic stem cell transplant: diagnostic dilemma and management considerations. J Clin Virol 45: 262-264, 2009.
11. Nakaseko C, Sakaida E, Ohwada C, et al. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia. Ann Hematol 86: 67-69, 2007.
18. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13: 2401-2407, 1995.
4. Cereda M, Trocino G, Pogliani EM, Schiavina R. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation. Ital Heart J 4: 60-63, 2003.
12. Mahfoud F, Gärtner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32: 897-903, 2011.
16. Yabe M, Ishiguro H, Yasuda Y, et al. Fatal giant cell myocarditis after allogeneic bone marrow transplantation. Bone Marrow Transplant 41: 93-94, 2008.
15. Rackley C, Schultz KR, Goldman FD, et al. Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant 11: 773-780, 2005.
1. Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res 118: 496-514, 2016.
9. Sumi M, Sato K, Kaiume H, et al. Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation. Leuk Lymphoma 58: 2005-2007, 2017.
10. Ravandi F, O'Brien S, Thomas D, et al. First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood 116: 2070-2077, 2010.
5. Ahn JS, Cho SH, Kim YK, et al. Polymyositis and myocarditis after donor lymphocyte infusion. Int J Hematol 90: 113-116, 2009.
14. Platzbecker U, Klingel K, Thiede C, et al. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 27: 107-109, 2001.
17. Wang YX, da Cunha V, Vincelette J, et al. Antiviral and myocyte protective effects of murine interferon-β and -α2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. Am J Physiol Heart Circ Physiol 293: H69-H76, 2007.
13. Henry K. Some ultrastructural aspects of bone marrow transplantation: hitherto unrecognized manifestations of GVHR involving heart, and polyoma virus infection in two children. Pathol Biol (Paris) 26: 55-65, 1978.
20. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30: 1995-2002, 2009.
3. Gilman AL, Kooy NW, Atkins DL, et al. Complete heart block in association with graft-versus-host disease. Bone Marrow Transplant 21: 85-88, 1998.
6. Morimoto Y, Oka S, Tashima M, Hamahata K, Nohgawa M. Chronic GVHD complicated with polymyositis and cardiomyopathy after myeloablative hematopoietic stem cell transplantation. Rinsho Ketsueki 56: 485-490, 2015 (in Japanese, Abstract in English).
7. Zinter MS, Barrows BD, Ursell PC, et al. Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. Bone Marrow Transplant 52: 1330-1333, 2017.
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
10
References_xml – reference: 3. Gilman AL, Kooy NW, Atkins DL, et al. Complete heart block in association with graft-versus-host disease. Bone Marrow Transplant 21: 85-88, 1998.
– reference: 11. Nakaseko C, Sakaida E, Ohwada C, et al. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia. Ann Hematol 86: 67-69, 2007.
– reference: 1. Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res 118: 496-514, 2016.
– reference: 17. Wang YX, da Cunha V, Vincelette J, et al. Antiviral and myocyte protective effects of murine interferon-β and -α2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. Am J Physiol Heart Circ Physiol 293: H69-H76, 2007.
– reference: 19. Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev 18: CD004471, 2013.
– reference: 9. Sumi M, Sato K, Kaiume H, et al. Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation. Leuk Lymphoma 58: 2005-2007, 2017.
– reference: 14. Platzbecker U, Klingel K, Thiede C, et al. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 27: 107-109, 2001.
– reference: 6. Morimoto Y, Oka S, Tashima M, Hamahata K, Nohgawa M. Chronic GVHD complicated with polymyositis and cardiomyopathy after myeloablative hematopoietic stem cell transplantation. Rinsho Ketsueki 56: 485-490, 2015 (in Japanese, Abstract in English).
– reference: 20. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30: 1995-2002, 2009.
– reference: 4. Cereda M, Trocino G, Pogliani EM, Schiavina R. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation. Ital Heart J 4: 60-63, 2003.
– reference: 2. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 59: 779-792, 2012.
– reference: 12. Mahfoud F, Gärtner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32: 897-903, 2011.
– reference: 13. Henry K. Some ultrastructural aspects of bone marrow transplantation: hitherto unrecognized manifestations of GVHR involving heart, and polyoma virus infection in two children. Pathol Biol (Paris) 26: 55-65, 1978.
– reference: 18. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13: 2401-2407, 1995.
– reference: 5. Ahn JS, Cho SH, Kim YK, et al. Polymyositis and myocarditis after donor lymphocyte infusion. Int J Hematol 90: 113-116, 2009.
– reference: 8. Bhattacharya S, Paneesha S, Chaganti S, et al. "Viral" myocarditis in a patient following allogenic stem cell transplant: diagnostic dilemma and management considerations. J Clin Virol 45: 262-264, 2009.
– reference: 10. Ravandi F, O'Brien S, Thomas D, et al. First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood 116: 2070-2077, 2010.
– reference: 15. Rackley C, Schultz KR, Goldman FD, et al. Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant 11: 773-780, 2005.
– reference: 7. Zinter MS, Barrows BD, Ursell PC, et al. Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. Bone Marrow Transplant 52: 1330-1333, 2017.
– reference: 16. Yabe M, Ishiguro H, Yasuda Y, et al. Fatal giant cell myocarditis after allogeneic bone marrow transplantation. Bone Marrow Transplant 41: 93-94, 2008.
– ident: 2
  doi: 10.1016/j.jacc.2011.09.074
– ident: 15
  doi: 10.1016/j.bbmt.2005.07.002
– ident: 17
  doi: 10.1152/ajpheart.00154.2007
– ident: 3
  doi: 10.1038/sj.bmt.1701038
– ident: 4
– ident: 6
  doi: 10.11406/rinketsu.56.485
– ident: 19
  doi: 10.1002/14651858.CD004471.pub3
– ident: 16
  doi: 10.1038/sj.bmt.1705869
– ident: 1
  doi: 10.1161/CIRCRESAHA.115.306573
– ident: 12
  doi: 10.1093/eurheartj/ehq493
– ident: 13
– ident: 9
  doi: 10.1080/10428194.2016.1266623
– ident: 5
  doi: 10.1007/s12185-009-0332-3
– ident: 14
  doi: 10.1038/sj.bmt.1702744
– ident: 7
  doi: 10.1038/bmt.2017.114
– ident: 11
  doi: 10.1007/s00277-006-0192-3
– ident: 10
  doi: 10.1182/blood-2009-12-261586
– ident: 8
– ident: 20
– ident: 18
  doi: 10.1200/JCO.1995.13.9.2401
SSID ssj0038792
Score 2.2433197
SecondaryResourceType review_article
Snippet A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance...
SourceID pubmedcentral
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 113
SubjectTerms Acute lymphoblastic leukemia
allogeneic stem cell transplantation
atrioventricular block
Atrioventricular Block - diagnosis
Atrioventricular Block - drug therapy
Atrioventricular Block - etiology
Case Report
Cord blood
Cord Blood Stem Cell Transplantation
Echocardiography
Electrocardiography
Female
Glucocorticoids - therapeutic use
Graft vs Host Disease - complications
Graft vs Host Disease - diagnosis
Graft vs Host Disease - drug therapy
graft-versus-host disease
Heart
Heart diseases
Humans
Internal medicine
Literature reviews
Lymphatic leukemia
Middle Aged
Myocarditis
Myocarditis - diagnosis
Myocarditis - drug therapy
Myocarditis - etiology
Myocardium
Philadelphia chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Prednisolone
Prednisolone - therapeutic use
Shock, Cardiogenic - diagnosis
Shock, Cardiogenic - etiology
Stem cell transplantation
Stem cells
Ventricle
α-Interferon
Title Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review
URI https://www.jstage.jst.go.jp/article/internalmedicine/59/1/59_3322-19/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/31462594
https://www.proquest.com/docview/2331454149
https://www.proquest.com/docview/2282504186
https://pubmed.ncbi.nlm.nih.gov/PMC6995704
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 2020/01/01, Vol.59(1), pp.113-118
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqghCXijcLpTIS15Q4dvxAQiisKOWxXGCl3iLHsUsgzcI2leiNn85MXmJLhRCXXOxJInvG8814HoQ8kbxgipkQMaNcJApWRpY7OAx5WsZMF0FyzB1efJCHS_H2KD3aImO64rCAp5eadthParmu9398P38BAv8cw5iZNE-r3ndWj7fR-xwtLKwFegX0k0JxXYjpboFr1bVKBkWJ-QdM9_E9f33ThtK6-gVw27G_DJJejKz8TVUd3CA7A8akWc8UN8mWb26Ra4vha7fJz8U5aDDgjLY6peiIpdkQCUCzdl2tMASy8wvaNX0Jyu4r7TqJ06yGgxLOxsrRj60_oXNf17Svjl7bPoWpeUYzOgfNSHtkT21T0vdT6WbaX0XcIcuDV5_mh9HQiSFyMjZtZIUNSRA2SQrtgrOlAhSognQAFkMBJkwc-8LEVsigjXZCFCaU2jrlQ8wTn_K7ZLtZNf4-oV7yAIzjY2UBqhUaAGZphNRaBARnbkbUuNS5G8qUY7eMOgdzBTcpv7hJOW5SzsyMsInyW1-q4x9oXve7OVEMAvsnRWpyho-BcpqI2XFwxMzI7sgO-cjFecI5E9hoHT70eBoGAcZbGdv41RnMwezhWDAtZ-Rezz3TzwA12qcCFmWDr6YJWBx8c6SpPndFwqUxqYrFg_9YlIfkeoJehc7RtEu22_WZfwTQqy32wOh4826vk6dfxmk4QA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myocarditis+with+Advanced+Atrioventricular+Block+after+Allogeneic+Stem+Cell+Transplantation%3A+A+Case+Report+and+Literature+Review&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=Sumi%2C+Masahiko&rft.au=Kitahara%2C+Mari&rft.au=Shishido%2C+Tsutomu&rft.au=Kazumoto%2C+Hiroko&rft.date=2020-01-01&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=59&rft.issue=1&rft.spage=113&rft.epage=118&rft_id=info:doi/10.2169%2Finternalmedicine.3322-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_2169_internalmedicine_3322_19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon